bioRxivCancer Biology
Locus specific human endogenous retroviruses reveal new lymphoma subtypes
B. Singh, N. Dopkins, T. Fei, J. L. Marston, S. Michael, H. Reyes-Gopar, G. Curty, J. J. Heymann, A. Chadburn, P. Martin, F. E. Leal, E. Cesarman, D. F. Nixon, M. L. Bendall
Abstract
The heterogeneity of cancers are driven by diverse mechanisms underlying oncogenesis such as differential cell-of-origin (COO) progenitors, mutagenesis, and viral infections. Classification of B-cell lymphomas have been defined by considering these characteristics. However, the expression and contribution of transposable elements (TEs) to B cell lymphoma oncogenesis or classification have been overlooked. We hypothesized that incorporating TE signatures would increase the resolution of B-cell identity during healthy and malignant conditions. Here, we present the first comprehensive, locus-specific characterization of TE expression in benign germinal center (GC) B-cells, diffuse large B-cell lymphoma (DLBCL), Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt lymphoma (BL), and follicular lymphoma (FL). Our findings demonstrate unique human endogenous retrovirus (HERV) signatures in the GC and lymphoma subtypes whose activity can be used in combination with gene expression to define B-cell lineage in lymphoid malignancies, highlighting the potential of retrotranscriptomic analyses as a tool in lymphoma classification, diagnosis, and the identification of novel treatment groups.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of a novel humanized heavy chain antibody targeting endogenous retroviruses with anti-lymphoma activity
F. Spriano, L. Cascione, … F. Bertoni·bioRxiv·Jan 17, 2024
- Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics
Quincy Rosemarie, Mitchell Hayes, Eric Johannsen·bioRxiv·Apr 4, 2026
- LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome
Amy Leung, Candi Trac, … Dustin E. Schones·Genome ResearchPeer-reviewed·Dec 1, 2018
- Targeting endogenous retrovirus gene transcription in human cancers
Audrey T. Lin, Cindy G. Santander, … Gkikas Magiorkinis·bioRxiv·Oct 28, 2018
- A common set of structurally distinct endogenous retroviruses predict survival in multiple human tumor types
A. L. Massa, H. Chintalapudi, … S. D. Leach·bioRxiv·Feb 7, 2024
- Retrovirus insertion site analysis of LGL leukemia patient genomes
Weiling Li, Lei Yang, … Mary L. Poss·BMC Medical GenomicsPeer-reviewed·Jun 17, 2019